Coretec sources raw materials for its silicon-based products, with a focus on cyclohexasilane (CHS) and its chemical derivatives. The company is developing a strategic partnership with a domestic supplier of silicon-based materials to support the development and scale-up of CHS and related materials. This partnership is intended to enable Coretec to supply large quantities of novel silicon materials for prototype batteries, electronics, and photovoltaic/solar cells. Additionally, Coretec is pursuing further strategic partnerships within the private sector to support its business and commercialization efforts.
The Coretec Group Inc's Comment on Supply Chain
Coretec sources raw materials for its silicon-based products, with a focus on cyclohexasilane (CHS) and its chemical derivatives. The company is developing a strategic partnership with a domestic supplier of silicon-based materials to support the development and scale-up of CHS and related materials. This partnership is intended to enable Coretec to supply large quantities of novel silicon materials for prototype batteries, electronics, and photovoltaic/solar cells. Additionally, Coretec is pursuing further strategic partnerships within the private sector to support its business and commercialization efforts.
Sources:
The Coretec Group Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on The Coretec Group Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
